Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karoly Toth

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
ACS Infectious Diseases|May 19, 2025
LAVR-289, an Orally Bioavailable Inhibitor of Adenovirus Replication <i>In Vitro</i> and <i>In Vivo</i>Charlotte Quentin-Froignant, Ann E Tollefson, Anna Cline-Smith, et al.
Human Gene Therapy|February 11, 2005
Cotton rat tumor model for the evaluation of oncolytic adenovirusesKaroly Toth, Jacqueline F Spencer, Ann E Tollefson, et al.
Antiviral Research|January 8, 2024
Oral USC-093, a novel homoserinamide analogue of the tyrosinamide (S)-HPMPA prodrug USC-087 has decreased nephrotoxicity while maintaining antiviral efficacy against human adenovirus infection of Syrian hamstersAnn E Tollefson, Samantha B Riemann, Baoling Ying, et al.
Cancer Research|August 21, 2013
Specific recruitment of γδ regulatory T cells in human breast cancerJian Ye, Chunling Ma, Fang Wang, et al.
Disease Models & Mechanisms|July 12, 2020
Generation and characterization of an <i>I</i><i>l2rg</i> knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patientsRong Li, Baoling Ying, Yanan Liu, et al.
Viruses|May 9, 2018
Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9Jinxin Miao, Baoling Ying, Rong Li, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2008
Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinomaMarwan G Fakih, Kelli Bullarddunn, Gary Y Yang, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2020
Filociclovir Is a Potent <i>In Vitro</i> and <i>In Vivo</i> Inhibitor of Human AdenovirusesKaroly Toth, Islam T M Hussein, Ann E Tollefson, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian HamstersKatrin Schaar, Anja Geisler, Milena Kraus, et al.
RSC Medicinal Chemistry|October 20, 2023
Identification of novel 1,2,3-triazole isatin derivatives as potent SARS-CoV-2 3CLpro inhibitors <i>via</i> click-chemistry-based rapid screeningXiangyi Jiang, Jing Li, Antonio Viayna, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
ACS Infectious Diseases|May 19, 2025
LAVR-289, an Orally Bioavailable Inhibitor of Adenovirus Replication <i>In Vitro</i> and <i>In Vivo</i>Charlotte Quentin-Froignant, Ann E Tollefson, Anna Cline-Smith, et al.
Human Gene Therapy|February 11, 2005
Cotton rat tumor model for the evaluation of oncolytic adenovirusesKaroly Toth, Jacqueline F Spencer, Ann E Tollefson, et al.
Antiviral Research|January 8, 2024
Oral USC-093, a novel homoserinamide analogue of the tyrosinamide (S)-HPMPA prodrug USC-087 has decreased nephrotoxicity while maintaining antiviral efficacy against human adenovirus infection of Syrian hamstersAnn E Tollefson, Samantha B Riemann, Baoling Ying, et al.
Cancer Research|August 21, 2013
Specific recruitment of γδ regulatory T cells in human breast cancerJian Ye, Chunling Ma, Fang Wang, et al.
Disease Models & Mechanisms|July 12, 2020
Generation and characterization of an <i>I</i><i>l2rg</i> knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patientsRong Li, Baoling Ying, Yanan Liu, et al.
Viruses|May 9, 2018
Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9Jinxin Miao, Baoling Ying, Rong Li, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2008
Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinomaMarwan G Fakih, Kelli Bullarddunn, Gary Y Yang, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2020
Filociclovir Is a Potent <i>In Vitro</i> and <i>In Vivo</i> Inhibitor of Human AdenovirusesKaroly Toth, Islam T M Hussein, Ann E Tollefson, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian HamstersKatrin Schaar, Anja Geisler, Milena Kraus, et al.
RSC Medicinal Chemistry|October 20, 2023
Identification of novel 1,2,3-triazole isatin derivatives as potent SARS-CoV-2 3CLpro inhibitors <i>via</i> click-chemistry-based rapid screeningXiangyi Jiang, Jing Li, Antonio Viayna, et al.
Pageof 7